gsk fda - Search News

News

GSK Falls

GSK falls as blood cancer drug likely headed for US rejection

GSK shares fell more than 6% on Friday to the bottom of Britain's blue-chip index after a U.S. FDA advisory panel recommended against approving its blood cancer drug Blenrep, citing earlier concerns over side effects.

Bloomberg on MSN · 1h

GSK Falls After FDA Advisory Panel Fails to Back Cancer Drug

GSK Plc shares tumbled after its blood cancer drug failed to secure the backing of a panel of US regulatory advisers, putting its approval in doubt.

Investing.com · 31m

GSK shares fall after FDA panel votes against Blenrep combinations for myeloma

Investing.com -- GSK (LON: GSK) shares dropped more than 6% on Friday after a U.S. Food and Drug Administration advisory panel voted against the benefit-risk profile of Blenrep (belantamab mafodotin-blmf) combinations for treating relapsed or refractory multiple myeloma.

Pharmaceutical Technology19m

FDA approves GSK’s prefilled syringe presentation of Shingrix

The FDA has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a prefilled syringe presentation to prevent shingles.

1h

FDA votes against overall benefit/risk profile of GSK's multiple myeloma candidate at proposed dosage

Drugmaker GSK said on Friday that the US Food and Drug Administration's Oncologic Drugs Advisory Committee had voted against ...

Stock Crash: MNC drugmaker shares tank after key drug fails to get regulatory panel nod

According to reports, the USFDA's Oncologic Advisory Committee voted that the risks from the drug, called Blenrep, outweighed ...

Fierce Pharma2d

As GSK eyes Blenrep's US return, FDA flags eye safety concerns ahead of advisory committee meeting

GSK has been enjoying regulatory momentum in recent months as it works to bring its antibody-drug conjugate (ADC) Blenrep ...

3don MSN

GSK seeks FDA nod for expanded use of RSV vaccine in adults

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results